4//SEC Filing
WALTON ALAN G 4
Accession 0001012975-07-000340
CIK 0001070494other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 7:22 PM ET
Size
10.3 KB
Accession
0001012975-07-000340
Insider Transaction Report
Form 4
WALTON ALAN G
Director
Transactions
- Award
Stock Option (Right to Buy)
2007-06-15+10,000→ 10,000 totalExercise: $15.02Exp: 2017-06-14→ Common Stock (10,000 underlying) - Award
Stock Option (Right to Buy)
2007-06-15+3,994→ 3,994 totalExercise: $15.02Exp: 2017-06-14→ Common Stock (3,994 underlying)
Footnotes (2)
- [F1]One-fourth of the shares subject to the Stock Option shall vest and become exercisable at the end of each three-month period following June 15, 2007.
- [F2]The Reporting Person has elected to convert annual retainer fees of $20,000 into a stock option under the terms of the Issuer's Outside Director Compensation Program.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001214273
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 7:22 PM ET
- Size
- 10.3 KB